Here’s the latest instalment in our news updates from Blackford Platform Partners.
Lung disease detection AI company Riverain Technologies announced the availability of a set of lung cancer awareness materials and tools for all providers to use during and after November, which is Lung Cancer Awareness Month. Medical diagnostic provider MaxQ AI announced the appointment of Eric Yablonka to its board of directors He brings more than 35 years of industry-leading healthcare technology experience advising and consulting companies, funds, and organizations on all matters relating to health information technologies, digital and business, and their applications. The CEO of lung analysis firm VIDA was featured in this article, where she commented on some of the factors contributing to the high failure rate of respiratory drugs, as well as some of the unique ways the company is working to improve that figure. Computer aided diagnostics company AZmed announced a clinical study to evaluate if the use of its RAYVOLVE software decreases the number of errors in the detection of limb fracture on standard radiographs by emergency physicians. The monocentric before-and-after observational study was conducted in the adult emergency department of the Niort Hospital (France).
Visualization and analytical solutions developer
Imaging Biometrics announced that its patented zero gadolinium MR technology, called IB Zero G has demonstrated a broad clinical application in
this new paper. AI-powered breast health solution provider
Densitas
announced that it has signed an agreement with RAD-AID International to deploy the densitas intellMammo AI software platform at Georgetown Public Hospital in Guyana.
Stay tuned for more partner news next month!